|
Angiotech appoints Laura Brege to its Board of Directors Angiotech Pharmaceuticals, Inc., a global specialty pharmaceutical and medical device company, today announced that Laura Brege has been appointed to its Board of Directors. Neuromed Appoints Mario Orlando as Vice President of Marketing InNexus Biotechnology Inc., a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, has appointed Dr. Jur Strobos to Chief Medical Officer. Med BioGene Inc.: Dr. Nathan Yoganathan, President and Chief Scientific Officer, Transitions to Senior Advisory Role; Dr. Bradley Mclean Appointed Chief Scientific Officer Med BioGene Inc., a biotechnology company developing genetic biomarkers to improve screening, diagnosis, prognosis and treatment decisions for patients suffering from cancer and cardiovascular disease, today announced that Dr. Nathan Yoganathan, MBI's founder, President and Chief Scientific Officer has transitioned to a senior advisory role as Chief Scientific Advisor. Dr. Bradley McLean, a senior scientist with MBI, was appointed Chief Scientific Officer. |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |